Back to search

Article

Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latency

2020-05-30

Abstract excerpt

Although thousands of breast cancer cells disseminate and home to bone marrow until primary surgery, usually less than a handful will succeed in establishing manifest metastases months to years later. To identify signals that support survival or outgrowth in patients, we profiled rare bone marrow-derived disseminated cancer cells (DCCs) long before manifestation of metastasis and identified IL6/PI3K-signaling as c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f423f60e-4c10-502a-a95a-1b89da826212
DOI
10.1101/2020.05.28.121145
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during periods of clinical latencyDOI 10.1101/2020.05.28.121145
Select a neighboring publication to make it the new centre.